Evaluation of Wear Experience With One Week Reusable Contact Lenses in Habitual Two Week Reusable Lens Wearers
NCT ID: NCT06382064
Last Updated: 2025-10-20
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
71 participants
INTERVENTIONAL
2024-04-16
2024-12-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Wear Experience With a Daily Disposable Contact Lens
NCT04296877
Acuvue Oaysis Contact Lens Wearers Being Refit Into P7 Contact Lenses
NCT06955403
Evaluation of Wear Experience With Daily Contact Lenses
NCT05096156
A 6-Hour Clinical Evaluation of New Daily-Wear Soft Contact Lenses
NCT03235089
Evaluation of Comfort for Two Marketed Daily Disposable Contact Lenses
NCT04968925
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Contact Lens Wear Experience
Participants will be enrolled in the study for 4 weeks. Biweekly replacement contact lenses will be worn for the first 2 weeks. One-week replacement lenses worn for second 2 weeks.
Biweekly replacement contact lenses
Biweekly replacement reusable contact lenses.
One week replacement contact lenses
One week replacement reusable contact lenses.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biweekly replacement contact lenses
Biweekly replacement reusable contact lenses.
One week replacement contact lenses
One week replacement reusable contact lenses.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Ability to give informed consent
3. Current Acuvue® Oasys® spherical lens wearer.
4. Distance visual acuity of 20/25 or better with current contact lenses in each eye.
5. Good general health defined by, medication use that has not changed within the last 30 days and the absence of medical conditions or treatments that are deemed confounding to the data as determined by the Investigator.
6. Willing to spend time for the study, which includes: attend three study visits and wear contact lenses on days between study visits.
Exclusion Criteria
2. Currently pregnant or lactating. (Participants will be asked to self-report these conditions).
3. Systemic inflammatory disease (i.e. Diabetes, etc.) that could confound study results in the opinion of the investigator.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ohio State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jennifer Fogt
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Ohio State University College of Optometry
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024H0089
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.